Management of patients with septic shock due to Candida infection

Hospital Practice
Matteo BassettiAlessandro Russo

Abstract

Septic shock represents a serious complication occurring between 6% and 30% of all hospitalized patients; Candida septic shock represents a challenge for clinicians due to the absence of specific risk factors, diagnostic tests, and management. Identification of specific risk factors and use of biomarkers are useful tools considering that differentiation of Candida from bacterial septic shock is demanding. Early effective antifungal treatment, preferably with echinocandins with an adequate source control, represents the best approach for improving survival of patients with septic shock due to Candida. Given the importance of adequate therapy and source control in septic shock attributable to Candida clinical strategies and pathways are needed. This review will focus on epidemiology of septic shock in patients with invasive candidiasis with special attention to diagnostic pathways and treatment strategies.

References

May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G T ColeE J Anaissie
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P WeinsteinL B Reller
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D PittetR P Wenzel
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
May 7, 2002·Critical Care Medicine·Per SandvenUNKNOWN NORGAS Group and the Norwegian Yeast Study Group
Aug 7, 2002·Critical Care Medicine·Susan HadleyStanley A Nasraway
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Jul 29, 2003·Expert Opinion on Investigational Drugs·Nathan P Wiederhold, Russell E Lewis
Jan 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oscar MarchettiUNKNOWN Fungal Infection Network of Switzerland
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam RaadGerald P Bodey
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zekaver OdabasiLuis Ostrosky-Zeichner
Jan 21, 2006·Critical Care Medicine·Jean-Louis VincentUNKNOWN Sepsis Occurrence in Acutely Ill Patients Investigators
Jan 31, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H WisplinghoffM B Edmond
Mar 1, 2006·Critical Care Medicine·Philippe MontraversClaude Martin
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin W GareyDavid T Bearden
Sep 15, 2006·The New England Journal of Medicine·John E Bennett
Jul 23, 2009·The Journal of Antimicrobial Chemotherapy·Matteo BassettiClaudio Viscoli
Sep 4, 2009·Journal of Cellular and Molecular Medicine·Peter A Ward, Hongwei Gao
Dec 3, 2009·JAMA : the Journal of the American Medical Association·Jean-Louis VincentUNKNOWN EPIC II Group of Investigators
Sep 10, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P MontraversUNKNOWN AmarCand study group
Dec 15, 2010·Critical Care : the Official Journal of the Critical Care Forum·Malgorzata MikulskaUNKNOWN Third European Conference on Infections in Leukemia Group
Dec 15, 2010·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiClaudio Viscoli
Feb 11, 2011·Current Infectious Disease Reports·Maurizio SanguinettiBrunella Posteraro
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Drosos E KarageorgopoulosMatthew E Falagas
Aug 4, 2011·Seminars in Immunopathology·Katerina OikonomopoulouJohn D Lambris
Oct 25, 2011·Critical Care : the Official Journal of the Critical Care Forum·Brunella PosteraroMassimo Antonelli
Jan 12, 2012·Journal of Chemotherapy·P K MukherjeeM A Ghannoum
Jan 12, 2012·International Journal of Microbiology·Donna M Maccallum
Mar 14, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R AndesUNKNOWN Mycoses Study Group
Mar 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin KollefAnand Kumar
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O A CornelyUNKNOWN ESCMID Fungal Infection Study Group
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·W W HopeUNKNOWN ESCMID Fungal Infection Study Group
Jan 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelius J Clancy, M Hong Nguyen
May 21, 2013·Trends in Microbiology·Gary B Huffnagle, Mairi C Noverr

❮ Previous
Next ❯

Citations

Mar 29, 2020·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiPatricia Muñoz
Oct 7, 2020·The Pediatric Infectious Disease Journal·Watsamon JantarabenjakulThanyawee Puthanakit
Jun 17, 2021·Infection·Vasiliki SoulountsiSerafeim Chrysovalantis Kotoulas
Oct 17, 2021·Critical Care : the Official Journal of the Critical Care Forum·Marin H KollefJose Garnacho-Montero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.